Journal for Managed Care & Specialty Pharmacy Issues Research Articles in April 2022 Edition

ALEXANDRIA, Virginia, March 26 -- The Journal for Managed Care and Specialty Pharmacy, a peer-reviewed journal that says it strives to engage and serve professionals in pharmacy, medicine, nursing and related fields to optimize the value of pharmaceutical products and pharmacy services delivered to patients from the Academy of Managed Care Pharmacy, published research articles on the following topics in its April 2022 edition:

Research:

* Cost-effectiveness and value of information analyses of Bruton's tyrosine kinase inhibitors in the treatment of relapsed or refractory mantle cell lymphoma in the United States

* The economic burden of Parkinson disease among Medicare beneficiaries

* Cardiorenal disease in the United States: Future health care burden and potential impact of novel therapies

* All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States

* Budget impact analysis of trilaciclib for decreasing the incidence of chemotherapy-induced myelosuppression in patients with extensive-stage small cell lung cancer in the United States

* Health care costs and resource utilization among commercially insured adult patients with hemophilia A managed with FVIII prophylaxis in the United States

* Dasiglucagon demonstrates reduced costs in the treatment of severe hypoglycemia in a budget impact model

* Comparing and validating medication complexity from insurance claims against electronic health records

The April 2022 edition of the Journal for Managed Care & Specialty Pharmacy can be viewed at https://www.jmcp.org/toc/jmcsp/28/4.